期刊文献+

星点设计-效应面法优化健脾颗粒的提取工艺 被引量:1

Optimization of the Extraction Process of Jianpi Granules by Central Composite Design-Response Surface Methodology
下载PDF
导出
摘要 目的:以星点设计-效应面法优选健脾颗粒的提取工艺。方法:以加水量和提取时间为自变量,以橙皮苷转移率为因变量对自变量各水平进行多元线性回归和二项式拟合,用效应面法选择较佳工艺条件,并进行预测分析。结果:确定较优提取工艺为加11倍量水,提取时间80 min,提取2次,提取率实测值与预测值偏差为0.54%,二项式拟合复相关系数r=0.958 3。结论:采用星点设计-效应面法优选健脾颗粒的提取工艺,方法简便,预测性良好。 Objective;To optimize the extraction process of Jianpi granules by central composite design-response surface methodology. Method:The independent variables were extraction time and water yield,and the dependent variable was extraction ratio of hesperidin. Linear or no-linear mathematic models were used to estimate the relationship between the independent and dependent variables. Response surface methodology was used to optimize the extraction process.Prediction was carried out through comparing the observed and predicted values.Result;The regression coefficient of binomial fitting complex model was as high as 0.958 3,the optimum extraction conditions were 80 min extraction,11-fold water and twice extraction.The bias between the observed and predicted values was 0.54%.Conclusion:Central composite design-response surface methodology is convenient and highly predictive for optimizing the extraction process of Jianpi granules.
出处 《中国药师》 CAS 2012年第12期1685-1688,共4页 China Pharmacist
关键词 橙皮苷 星点设计 效应面优化法 健脾颗粒 提取工艺 Hesperidin Central composite design Response surface methodology Jianpi granules Extraction process
  • 相关文献

参考文献5

二级参考文献12

  • 1Gatti G, Peruua E. Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidycholine complex in healthy volunteers[ J]. In J clin pharmacol Ther,1994,32( 11 ) :614-619. 被引量:1
  • 2Bhattachar SN, Howard R J, Tommoa I. The effects of complexation with hydrogenated phospholipids on the transports of salicylic acid, diclofenac and indomethacin across snake stratum comeum [ J ]. lnt J Pharm, 1992,79 : 263 -267. 被引量:1
  • 3Bombardelli E, Patri G, Pozzi R. Complexes of neolignane derivatives with phospholipids and pharmaceutical and cosmetic formulations containing them [ P ] . USA : 464297, 1992-01-08. 被引量:1
  • 4中国药典一部[S].2005:199-200. 被引量:76
  • 5江苏新医药学院.中药大辞典下册[M].上海:上海人民出版社,1977:2019. 被引量:1
  • 6Sébastien Branchu,Robert T. Forbes,Peter York,H?kan Nyqvist. A Central Composite Design to Investigate the Thermal Stabilization of Lysozyme[J] 1999,Pharmaceutical Research(5):702~708 被引量:1
  • 7Emad Eldin Hassan,Roy C. Parish,James M. Gallo. Optimized Formulation of Magnetic Chitosan Microspheres Containing the Anticancer Agent, Oxantrazole[J] 1992,Pharmaceutical Research(3):390~397 被引量:1
  • 8钟华林,黎晓华.高效液相色谱法测定千金保孕丸中黄芩苷的含量[J].中国实验方剂学杂志,2008,14(1):2-4. 被引量:5
  • 9姚仲青,金芳.HPLC法测定黄连上清丸中黄芩苷含量[J].中草药,1999,30(8):590-590. 被引量:13
  • 10邵礼铮,周干南,於洪建.中药复方制剂抗毒灵注射液中黄芩甙的含量测定[J].中草药,1990,21(7):18-18. 被引量:11

共引文献485

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部